Oracle Investment Management as of June 30, 2016
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 19 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 17.0 | $73M | 5.1M | 14.39 | |
| NxStage Medical | 13.5 | $58M | 2.7M | 21.68 | |
| Tesaro | 13.1 | $56M | 667k | 84.05 | |
| Mazor Robotics Ltd. equities | 11.6 | $50M | 2.8M | 17.98 | |
| Quidel Corporation | 10.5 | $45M | 2.5M | 17.86 | |
| Opko Health (OPK) | 8.5 | $37M | 3.9M | 9.34 | |
| Pacific Biosciences of California (PACB) | 5.2 | $22M | 3.2M | 7.03 | |
| Accuray Incorporated (ARAY) | 3.0 | $13M | 2.5M | 5.19 | |
| Biolase Technology | 2.9 | $12M | 11M | 1.17 | |
| Amarin Corporation (AMRN) | 2.9 | $12M | 5.7M | 2.16 | |
| Hansen Medical | 2.7 | $12M | 4.5M | 2.61 | |
| Intrexon | 2.6 | $11M | 460k | 24.61 | |
| Vermillion | 2.2 | $9.6M | 8.6M | 1.11 | |
| shares Agenus | 1.8 | $7.5M | 1.9M | 4.05 | |
| Transition Therapeutics | 1.3 | $5.6M | 3.8M | 1.47 | |
| Contrafect | 0.8 | $3.4M | 1.2M | 2.89 | |
| Biogen Idec (BIIB) | 0.4 | $1.6M | 6.7k | 241.71 | |
| Second Sight Med Prods | 0.0 | $182k | 51k | 3.58 | |
| ZIOPHARM Oncology | 0.0 | $37k | 6.7k | 5.55 |
